- Home
- TRVI vs ALX Comparison
TRVI vs ALX Comparison
Compare TRVI & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- ALX
- Stock Information
- Founded
- TRVI 2011
- ALX 1928
- Country
- TRVI United States
- ALX United States
- Employees
- TRVI N/A
- ALX N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- TRVI Health Care
- ALX Real Estate
- Exchange
- TRVI Nasdaq
- ALX Nasdaq
- Market Cap
- TRVI 1.1B
- ALX 1.2B
- IPO Year
- TRVI 2019
- ALX N/A
- Fundamental
- Price
- TRVI $10.65
- ALX $232.11
- Analyst Decision
- TRVI Strong Buy
- ALX
- Analyst Count
- TRVI 9
- ALX 0
- Target Price
- TRVI $20.72
- ALX N/A
- AVG Volume (30 Days)
- TRVI 2.0M
- ALX 83.9K
- Earning Date
- TRVI 11-05-2025
- ALX 11-03-2025
- Dividend Yield
- TRVI N/A
- ALX 7.75%
- EPS Growth
- TRVI N/A
- ALX N/A
- EPS
- TRVI N/A
- ALX 7.28
- Revenue
- TRVI N/A
- ALX $218,089,000.00
- Revenue This Year
- TRVI N/A
- ALX N/A
- Revenue Next Year
- TRVI N/A
- ALX N/A
- P/E Ratio
- TRVI N/A
- ALX $32.54
- Revenue Growth
- TRVI N/A
- ALX N/A
- 52 Week Low
- TRVI $2.36
- ALX $184.76
- 52 Week High
- TRVI $11.11
- ALX $260.84
- Technical
- Relative Strength Index (RSI)
- TRVI 71.22
- ALX 46.56
- Support Level
- TRVI $9.29
- ALX $228.05
- Resistance Level
- TRVI $10.04
- ALX $243.60
- Average True Range (ATR)
- TRVI 0.57
- ALX 6.54
- MACD
- TRVI 0.07
- ALX -0.63
- Stochastic Oscillator
- TRVI 82.67
- ALX 22.85
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.